| Human papillomavirus and survival of patients with oropharyngeal cancer KK Ang, J Harris, R Wheeler, R Weber, DI Rosenthal, PF Nguyen-Tân, ... New England Journal of Medicine 363 (1), 24-35, 2010 | 7202 | 2010 |
| Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522 KK Ang, Q Zhang, DI Rosenthal, PF Nguyen-Tan, EJ Sherman, RS Weber, ... Journal of clinical oncology 32 (27), 2940-2950, 2014 | 874 | 2014 |
| Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer M Vallieres, E Kay-Rivest, LJ Perrin, X Liem, C Furstoss, HJWL Aerts, ... Scientific reports 7 (1), 10117, 2017 | 574 | 2017 |
| Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma C Fakhry, Q Zhang, PF Nguyen-Tan, D Rosenthal, A El-Naggar, ... Journal of clinical oncology 32 (30), 3365-3373, 2014 | 553 | 2014 |
| Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy … PF Nguyen-Tan, Q Zhang, KK Ang, RS Weber, DI Rosenthal, D Soulieres, ... Journal of Clinical Oncology 32 (34), 3858-3867, 2014 | 518 | 2014 |
| Institutional clinical trial accrual volume and survival of patients with head and neck cancer EJ Wuthrick, Q Zhang, M Machtay, DI Rosenthal, PF Nguyen-Tan, A Fortin, ... Journal of Clinical Oncology 33 (2), 156-164, 2015 | 261 | 2015 |
| A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC). KK Ang, QE Zhang, DI Rosenthal, P Nguyen-Tan, EJ Sherman, RS Weber, ... Journal of Clinical Oncology 29 (15_suppl), 5500-5500, 2011 | 222 | 2011 |
| Treatment results and prognostic factors of advanced T3–4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience PF Nguyen-Tan, QT Le, JM Quivey, M Singer, DJ Terris, DR Goffinet, ... International Journal of Radiation Oncology* Biology* Physics 50 (5), 1172-1180, 2001 | 160 | 2001 |
| Development and validation of nomograms predictive of overall and progression-free survival in patients with oropharyngeal cancer C Fakhry, Q Zhang, PF Nguyen-Tân, DI Rosenthal, RS Weber, L Lambert, ... Journal of Clinical Oncology 35 (36), 4057-4065, 2017 | 144 | 2017 |
| Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy C Xiao, A Hanlon, Q Zhang, K Ang, DI Rosenthal, PF Nguyen-Tan, H Kim, ... Oral oncology 49 (4), 360-366, 2013 | 121 | 2013 |
| A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck ARA Razak, D Soulieres, SA Laurie, SJ Hotte, S Singh, E Winquist, ... Annals of oncology 24 (3), 761-769, 2013 | 116 | 2013 |
| Survival outcomes by tumor human papillomavirus (HPV) status in stage III-IV oropharyngeal cancer (OPC) in RTOG 0129 ML Gillison, J Harris, W Westra, C Chung, R Jordan, D Rosenthal, ... Journal of Clinical Oncology 27 (15_suppl), 6003-6003, 2009 | 116 | 2009 |
| Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol NJ Farsi, MC Rousseau, N Schlecht, G Castonguay, P Allison, ... Carcinogenesis 38 (12), 1188-1195, 2017 | 95 | 2017 |
| 18F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer G Delouya, L Igidbashian, A Houle, M Bélair, L Boucher, C Cohade, ... Radiotherapy and Oncology 101 (3), 362-368, 2011 | 91 | 2011 |
| Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: are we succeeding? L Lambert, B Fortin, D Soulières, L Guertin, G Coulombe, D Charpentier, ... International Journal of Radiation Oncology* Biology* Physics 76 (2), 398-402, 2010 | 87 | 2010 |
| Impact of weight loss on survival after chemoradiation for locally advanced head and neck cancer: secondary results of a randomized phase III trial (SAKK 10/94) P Ghadjar, S Hayoz, F Zimmermann, S Bodis, D Kaul, H Badakhshi, ... Radiation oncology 10, 1-7, 2015 | 81 | 2015 |
| Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: a single-institution experience using a reactive approach S Clavel, B Fortin, P Després, D Donath, D Soulières, N Khaouam, ... International Journal of Radiation Oncology* Biology* Physics 79 (3), 763-769, 2011 | 71 | 2011 |
| The KRAS-variant and cetuximab response in head and neck squamous cell cancer: a secondary analysis of a randomized clinical trial JB Weidhaas, J Harris, D Schaue, AM Chen, R Chin, R Axelrod, ... JAMA oncology 3 (4), 483-491, 2017 | 69 | 2017 |
| Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil … S Clavel, DHA Nguyen, B Fortin, P Després, N Khaouam, D Donath, ... International Journal of Radiation Oncology* Biology* Physics 82 (2), 582-589, 2012 | 68 | 2012 |
| Validation of NRG oncology/RTOG‐0129 risk groups for HPV‐positive and HPV‐negative oropharyngeal squamous cell cancer: implications for risk‐based therapeutic intensity trials C Fakhry, Q Zhang, ML Gillison, PF Nguyen‐Tân, DI Rosenthal, ... Cancer 125 (12), 2027-2038, 2019 | 65 | 2019 |
